Advertise | About Us | Contact Us

Article - Issue 63

Reimagining Pharmacovigilance

Article - Issue 63

Beyond Trial and Error

- Issue 63

AI and Computational Modeling Approaches for Dose Optimisation During Drug Development

Article - Issue 63

Beyond Human Intuition

Article - Issue 63

Artificial Intelligence (AI) - From promise to practice

EDITORIAL SECTIONS

Why X-ray Inspection is a Viable Quality Assurance Solution for Pharma Products

Adopting the Power of AI to Drug Development Projects

A tremendous amount of documentation is created throughout the clinical trial lifecycle

Real-world Evidence

Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA

Just in Time Manufacturing Creating more sustainable supply chains

Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine

Challenges and Advantages of Using Artificial Intelligence in Pharma

Many advanced largescale AI initiatives still need to be proved successful in Pharma

Advisory Board

Victor M. Diaz Perez

Brian D Smith

Nigel Cryer FRSC

Quang Bui

Tamara Miller

Imedla Leslie Rillon

Andri Kusandri

Nicoleta Grecu

Alessio Piccoli

Pramod Kashid

Neil J Campbell

The Human Side of Pharma BD: Patience, Persistence, and Truly Understanding Client Needs

Client Relations Officer, PozeScaf Inc
Pragathi Yadhati is a Client Relations Officer at PozeScaf Inc and Chief Business Officer for healthtech startups ScribeJoy and NuMd Since she has advised pharma organisations on relationshipfocused business development and strategic partnerships fundraising and connecting companies with investors She served on the advisory board of IIT Jodhpur and brought a peoplecentered empathetic approach to...

Articles

Data-Enriched Edible Pharmaceuticals (DEEP) as Patient-Tailored Drug Products

Patienttailored treatment can be a challenge with conventional

Research Insights

Deregulation of Exosomal miRNAs in Rheumatoid Arthritis Patients

Rheumatoid arthritis is referred to as a common inflammatory joint disorder The associated symptoms are inflammation and lifetime joint dysfunction and increased mortality rate The prevalence of RA in Western countries is approximately

Case Studies

Unusual Drug Response And Hemodynamics In VA – ECMO : A Drug Case Study

Abstract Maintaining higher sedation in patients undergoing ECMO therapy is crucial Currently no definite sedation strategy has been proposed in the literature as the pharmacokinetics of the medications in these patients is still not clear We would like to report a case of a patient with uncontrollable diverse clinical response to medications during arteriovenou

Techno Trends

China Implements New Regulatory Framework for Biopharmaceutical Innovation

China has announced a comprehensive overhaul of its regulatory policies aimed at fostering innovation in the biopharmaceutical sector

White Papers

Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches

In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS

Why tier-2 and tier-3 cities are not included for clinical research

Krutikesh Age

Co-Founder at DPHS Pvt. Ltd., Dr. Krutikesh Age is a researcher and a visionary committed towards propelling the field of clinical research and healthcare expansion in India. As the Co-founder of DPHS, Krutikesh manages varied key roles including Leadership, developing business and marketing strategies and Networking to name a few. It is through the deep understanding of clinical research and market dynamics that he has been instrumental in expanding the operations of DPHS in the past few years.

The Role of Genomics in Shaping the Future of Medicine

Smita Agrawal

Smita Agrawal holds a PhD in Chemical Engineering from the University of California, Berkeley. She has over 20 years of research experience in stem cell biology, neuroscience, immunology, genomics, oncology and real-world data. She currently serves as an independent consultant, offering strategic guidance and insights to life sciences companies on genomics, AI, and health care data applications.

3D Printing

Stéphane Roulon

Stéphane Roulon is a pharmaceutical entrepreneur with over ten years of experience in developing 3D printing technologies for drug manufacturing. He is the CEO of MB Therapeutics, a pharmaceutical establishment specializing in personalized medicines produced using advanced 3D printing solutions to support the future of precision medicine.

How PBM's Transformed to Provide Easy Access to Prescription Drugs Post COVID 19

Ravi Iyer

Technology Executive - Big Data, Analytics, Cloud, Digital, Elevance Health, Inc.

Narasimha Reddy Nalamalapu

Narasimha is result driven leader with vast experience in executing various PBM, Health care, Financial, and securities trading applications. Technical expertise in Big data, Cloud, Analytics, Mainframe, BPM, testing, and Data warehouse projects at esteemed organizations like Anthem, Tetrasoft, DST, HCL, Deutsche bank, and Atos Origin. He currently works as Solution Architect at Tetrasoft Inc.
.Narasimha has vast experience in Pre-sales, Project management, effective customer communication, Architect, Technical Lead, On-site coordinator, and business Analyst roles for various complex assignments across the globe.

Meet scientist Daria Donati

Daria Donati

Daria’s work is ongoing. Her role at Cytiva involves identifying new and innovative technologies that can help in the development of therapeutics. This means building partnerships, improving manufacturing processes and, ultimately, getting life- saving drugs to the people who need them most.

INDUSTRY UPDATES

press releasesRead more...

BIX 2026 Names Canada as Country of Honor Showcasing Bioindustry Trends from BCI To Biotech Foods

BIOPLUSINTERPHEX KOREA BIX Koreas largest biotechnology and pharmaceutical convention will be held at COEX in Seoul from October to Supported by the Ministry of Trade Industry and Resources this years BIX will feature over companies from around the world Canada will participate as the Country o...

Innovent Biologics announced a strategic collaboration with Eli Lilly on research and development and licensing.

Innovent Biologics SSE HKSE a hightech biopharmaceutical company today announced a strategic collaboration agreement with Eli Lilly and Company for research and licensing focusing on the development of innovative drugs

Cellares and Seoul National University Hospital Launch Proof-of-Concept for Automated Manufacturing of Gene-Modified HSPC Therapy on the Cell Shuttle® Platform

Cellares the first Integrated Development and Manufacturing Organization IDMO and Seoul National University Hospital SNUH a leading translational medical center in South Korea today announced a partnership

Zymeworks Completes Acquisition of Theravance Biopharma

Zymeworks Inc Nasdaq ZYME a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel multifunctional biotherapeutics today completed

UofG announces second research collaboration with Eli Lilly and Company for immune-related diseases

Worldchanging experts at the University of Glasgow will partner with scientists at leading pharmaceutical company Eli Lilly and Company Lilly to tackle immunerelated diseases

Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development

Thermo Fisher Scientific the world leader in serving science today announced the Gibco CHOK Catalog Panel a cGMPready portfolio of basal and feed media designed to support strong